Literature DB >> 15882835

Clinical assessment of the entry into neurological state in rat experimental African trypanosomiasis.

Céline Chevrier1, Frédéric Canini, Annabelle Darsaud, Raymond Cespuglio, Alain Buguet, Lionel Bourdon.   

Abstract

Human African trypanosomiasis, caused by Trypanosoma brucei (T.b.) gambiense or rhodesiense, evolves in two stages: haemolymphatic stage and meningo-encephalitic stages, the latter featuring numerous neurological disorders. In experimental models infected with diverse T.b. sub-species, body weight (BW) loss, drop in food intake (FI), and hypo-activity after an asymptomatic period suggest the occurrence of a similar two-stage organization. In addition to daily measurement of BW and FI, body core temperature (T(co)) and spontaneous activity (SA) were recorded by telemetry in T.b. brucei-infected rats. After a 10--12-day symptom-free period, a complex clinical syndrome occurred suddenly. If the animal survived the access, the syndrome re-occurred at approximately 5-day intervals until death. The syndrome was made of a drop in FI and BW, a sharp decrease in T(co) and a loss of SA, suggesting a brisk alteration of the central nervous system functioning. Such events confirm the existence of a two-stage disease development in experimental trypanosomiasis. The entry into the second stage is marked by the occurrence of the first access, BW follow-up being essential and often sufficient its determination.

Entities:  

Mesh:

Year:  2005        PMID: 15882835     DOI: 10.1016/j.actatropica.2005.04.011

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  6 in total

1.  Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.

Authors:  G Caljon; V Caveliers; T Lahoutte; B Stijlemans; G H Ghassabeh; J Van Den Abbeele; I Smolders; P De Baetselier; Y Michotte; S Muyldermans; S Magez; R Clinckers
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Clock gene expression during chronic inflammation induced by infection with Trypanosoma brucei brucei in rats.

Authors:  Gabriella B S Lundkvist; Michael T Sellix; Mikael Nygård; Erin Davis; Marty Straume; Krister Kristensson; Gene D Block
Journal:  J Biol Rhythms       Date:  2010-04       Impact factor: 3.182

3.  A panel of Trypanosoma brucei strains tagged with blue and red-shifted luciferases for bioluminescent imaging in murine infection models.

Authors:  Nick Van Reet; Hélène Van de Vyver; Patient Pati Pyana; Anne Marie Van der Linden; Philippe Büscher
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

4.  Trypanosoma brucei Invasion and T-Cell Infiltration of the Brain Parenchyma in Experimental Sleeping Sickness: Timing and Correlation with Functional Changes.

Authors:  Claudia Laperchia; Maria Palomba; Paul F Seke Etet; Jean Rodgers; Barbara Bradley; Paul Montague; Gigliola Grassi-Zucconi; Peter G E Kennedy; Marina Bentivoglio
Journal:  PLoS Negl Trop Dis       Date:  2016-12-21

5.  Cerebral and peripheral changes occurring in nitric oxide (NO) synthesis in a rat model of sleeping sickness: identification of brain iNOS expressing cells.

Authors:  Donia Amrouni; Sabine Gautier-Sauvigné; Anne Meiller; Philippe Vincendeau; Bernard Bouteille; Alain Buguet; Raymond Cespuglio
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

6.  Early invasion of brain parenchyma by African trypanosomes.

Authors:  Ute Frevert; Alexandru Movila; Olga V Nikolskaia; Jayne Raper; Zachary B Mackey; Maha Abdulla; James McKerrow; Dennis J Grab
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.